Why the study?
Does anticoagulant therapy affect the rate of foetal loss in pregnant patients with prosthetic heart valves?
Does anticoagulant therapy affect the rate of foetal loss in pregnant patients with prosthetic heart valves?
In pregnant patients with prosthetic heart valves, the use of anticoagulant therapy was associated with a higher rate of foetal loss compared to those not receiving anticoagulants.
Anticoagulant therapy was associated with higher foetal loss in prosthetic valve pregnancies; leaves open optimal regimens pending randomized data.
Between 1974 and 1981, 27 patients became pregnant agter prosthetic heart valve replacement with a total of 45 pregnancies. Four pregnancies terminated in therapeutic abortions. Of the remaining 41 pregnancies, 30 were associated with the use of anticoagulants and 11 not. Haemorrhage related to anitcoagulant therapy occurred in one patient. Thse foetal loss in the group with anticoagulant therapy was 33 per cent (10 abortions) and that in the group without was 9 per cent (one abortion). The use of aspirin and dipyridamole during pregnancy (eight pregnancies) did not appear to threaten the outcome of pregnancy. A total of 30 babies were born alive 20 per cent of them were light for date. There was no perinatal mortality. The typical warfarin embryopathy was notfound. Congenital anomalies in four newborns included congenital hydrocephalus, harelip and complete cleft palate, bilateral accessory auriclies and bilateral incurving 5th fingers. Subsequently, all except the newborn with congenital hydrocephalus showed normal development milestones.
No takes yet. Share an insight, caveat, or question.
Chen et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: